epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data.

DNA methylation epigenetic mosaicism epigenetics methylation sequencing somatic mosaicism

Journal

GigaScience
ISSN: 2047-217X
Titre abrégé: Gigascience
Pays: United States
ID NLM: 101596872

Informations de publication

Date de publication:
28 12 2022
Historique:
received: 01 06 2023
revised: 03 08 2023
accepted: 26 09 2023
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

Low-level mosaic epimutations within the BRCA1 gene promoter occur in 5-8% of healthy individuals and are associated with a significantly elevated risk of breast and ovarian cancer. Similar events may also affect other tumor suppressor genes, potentially being a significant contributor to cancer burden. While this opens a new area for translational research, detection of low-level mosaic epigenetic events requires highly sensitive and robust methodology for methylation analysis. We here present epialleleR, a computational framework for sensitive detection, quantification, and visualization of mosaic epimutations in methylation sequencing data. Analyzing simulated and real data sets, we provide in-depth assessments of epialleleR performance and show that linkage to epihaplotype data is necessary to detect low-level methylation events. The epialleleR is freely available at https://github.com/BBCG/epialleleR and https://bioconductor.org/packages/epialleleR/ as an open-source R/Bioconductor package.

Identifiants

pubmed: 37919976
pii: 7334271
doi: 10.1093/gigascience/giad087
pmc: PMC10622323
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press GigaScience.

Références

Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Cell Stress. 2019 Mar 22;3(4):118-135
pubmed: 31225507
Clin Epigenetics. 2020 Aug 28;12(1):131
pubmed: 32859265
Trends Genet. 2014 Dec;30(12):519-20
pubmed: 25301328
Eur J Cancer. 2010 Oct;46(15):2788-98
pubmed: 20627535
Bioinformatics. 2021 Dec 22;38(1):133-140
pubmed: 34383893
Nucleic Acids Res. 2021 Nov 8;49(19):e109
pubmed: 34320181
Virchows Arch. 2014 Nov;465(5):579-86
pubmed: 25031012
BMC Genomics. 2020 Mar 30;21(1):270
pubmed: 32228436
J Natl Cancer Inst. 2000 Apr 5;92(7):564-9
pubmed: 10749912
Blood Sci. 2021 Dec 6;4(1):8-15
pubmed: 35399541
BMC Evol Biol. 2020 Feb 27;20(1):33
pubmed: 32106815
Gigascience. 2021 Feb 16;10(2):
pubmed: 33594436
Hum Mol Genet. 1999 Apr;8(4):661-6
pubmed: 10072435
NAR Genom Bioinform. 2021 Mar 27;3(1):lqab019
pubmed: 33817639
Ann Intern Med. 2018 Mar 6;168(5):326-334
pubmed: 29335712
Genome Res. 2021 Jan 19;:
pubmed: 33468551
NAR Cancer. 2021 Jul 09;3(3):zcab028
pubmed: 34316715
G3 (Bethesda). 2016 Apr 07;6(4):973-86
pubmed: 26888867
Epigenetics Chromatin. 2018 Jun 29;11(1):37
pubmed: 29958539
PLoS One. 2012;7(4):e36263
pubmed: 22558411
Genome Biol. 2017 Aug 16;18(1):155
pubmed: 28814343
PLoS One. 2012;7(7):e41361
pubmed: 22848472
Ann Oncol. 2021 Feb;32(2):240-249
pubmed: 33242536
Int J Cancer. 2020 Mar 1;146(5):1293-1298
pubmed: 31469414
Gigascience. 2022 Dec 28;12:
pubmed: 37919976
Epigenetics. 2016 May 3;11(5):354-62
pubmed: 27019159
Front Oncol. 2020 Jan 17;9:1547
pubmed: 32010632
Genome Biol. 2012 Oct 03;13(10):R87
pubmed: 23034086
Hum Mol Genet. 2014 Sep 15;23(R1):R83-8
pubmed: 24927738
Nat Commun. 2018 Sep 28;9(1):3970
pubmed: 30266954
Cancer Cell. 2011 Feb 15;19(2):273-82
pubmed: 21316605
Cancer Res. 2021 Sep 15;81(18):4709-4722
pubmed: 34321239
Brief Bioinform. 2019 Jan 18;20(1):33-46
pubmed: 28981571
Sci Rep. 2019 Jul 17;9(1):10383
pubmed: 31316107
F1000Res. 2016 Jun 08;5:1281
pubmed: 27347385
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
Bioinformatics. 2017 Feb 15;33(4):558-560
pubmed: 28035024
Genome Biol. 2014 Sep 27;15(9):472
pubmed: 25260792
PLoS One. 2018 Jun 14;13(6):e0199091
pubmed: 29902267
JAMA Oncol. 2022 Nov 1;8(11):1579-1587
pubmed: 36074460
J Clin Oncol. 2010 Oct 10;28(29):e563-4; author reply e565-6
pubmed: 20679605
Biochim Biophys Acta. 2016 Apr;1865(2):275-88
pubmed: 27085853
Nucleic Acids Res. 2020 May 7;48(8):e46
pubmed: 32103242
Curr Top Microbiol Immunol. 2006;310:45-59
pubmed: 16909906
Clin Epigenetics. 2022 Feb 28;14(1):31
pubmed: 35227298

Auteurs

Oleksii Nikolaienko (O)

K. G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen 5021, Norway.

Per Eystein Lønning (PE)

K. G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen 5021, Norway.
Department of Oncology, Haukeland University Hospital, Bergen 5021, Norway.

Stian Knappskog (S)

K. G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen 5021, Norway.
Department of Oncology, Haukeland University Hospital, Bergen 5021, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH